Evaluation of circulating tumor DNA as a prognostic biomarker for metastatic pancreatic adenocarcinoma

PURPOSE: Pancreatic cancer is an aggressive solid tumor with a severe prognosis. Although tumor biomarkers are often used to identify advanced pancreatic cancer, this is not accurate, and the currently used biomarkers are not indicative of prognosis. The present study evaluated circulating tumor DNA...

Descripción completa

Detalles Bibliográficos
Autores principales: Guan, Shasha, Deng, Guochao, Sun, Jingjie, Han, Quanli, Lv, Yao, Xue, Tianhui, Ding, Lijuan, Yang, Tongxin, Qian, Niansong, Dai, Guanghai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9446234/
https://www.ncbi.nlm.nih.gov/pubmed/36081557
http://dx.doi.org/10.3389/fonc.2022.926260

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9446234/
https://www.ncbi.nlm.nih.gov/pubmed/36081557
http://dx.doi.org/10.3389/fonc.2022.926260

Ejemplares similares